Myasthenia gravis - Consequences for pregnancy, delivery, and the newborn

被引:77
作者
Hoff, JM [1 ]
Daltveit, AK
Gilhus, NE
机构
[1] Univ Bergen, Inst Neurol, N-5021 Bergen, Norway
[2] Univ Bergen, Sect Prevent Med, N-5021 Bergen, Norway
[3] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5021 Bergen, Norway
[4] Univ Bergen, Med Birth Registry Norway, N-5021 Bergen, Norway
[5] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway
关键词
D O I
10.1212/01.WNL.0000082725.21444.EC
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the effect of maternal myasthenia gravis (MG) on giving birth and on the newborn. Methods: A retrospective cohort study for 1967 through 2000 was undertaken, using data from the Medical Birth Registry of Norway, based on the compulsory notification of all births. The target group consisted of 127 births by mothers with MG. The reference group consisted of all 1.9 million births by mothers without MG. Results: Women with MG had a higher rate of complications at delivery (40.9% vs 32.9%, p=0.05), and in particular the risk of preterm rupture of amniotic membranes was three times higher in the MG group compared to the reference group (5.5% vs 1.7%, p=0.001). The rate of interventions during birth was raised (33.9% vs 20.0%, p<0.001) and cesarean sections doubled (17.3% vs 8.6%, p=0.001). Five children (3.9%) born by MG mothers had severe anomalies, and three of them died. Conclusions: MG is associated with an increased risk for complications during delivery. This is linked to a higher occurrence of interventions during birth.
引用
收藏
页码:1362 / 1366
页数:5
相关论文
共 29 条
[1]   Epidemiology of myasthenia gravis in northwestern Sardinia [J].
Aiello, I ;
Pastorino, N ;
Sotgiu, S ;
Pirastru, MI ;
Sau, GF ;
Sanna, G ;
Rosati, G .
NEUROEPIDEMIOLOGY, 1997, 16 (04) :199-206
[2]   Course and treatment of myasthenia gravis during pregnancy [J].
Batocchi, AP ;
Majolini, L ;
Evoli, A ;
Lino, MM ;
Minisci, C ;
Tonali, P .
NEUROLOGY, 1999, 52 (03) :447-452
[3]  
BATOCCHI AP, 2001, TOPICS NEUROSCI, P28
[4]  
CURTIN SC, 1999, NATL VITAL STAT REP, V47, P27
[5]   Myasthenia gravis in pregnancy: report on 69 cases [J].
Djelmis, J ;
Sostarko, M ;
Mayer, D ;
Ivanisevic, M .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2002, 104 (01) :21-25
[6]   ITALY HAS EUROPE HIGHEST CESAREAN-SECTION RATE [J].
EVANS, L .
BRITISH MEDICAL JOURNAL, 1995, 310 (6978) :487-487
[7]  
FURNES A, 1988, TIDSSKR NOR LAEGEFOR, V15, P1199
[8]   EVALUATION OF PRETERM DELIVERY IN A SYSTEMIC LUPUS-ERYTHEMATOSUS PREGNANCY CLINIC [J].
JOHNSON, MJ ;
PETRI, M ;
WITTER, FR ;
REPKE, JT .
OBSTETRICS AND GYNECOLOGY, 1995, 86 (03) :396-399
[9]   REPRODUCTIVE AND DEVELOPMENTAL TOXICITY STUDIES OF PYRIDOSTIGMINE BROMIDE IN RATS [J].
LEVINE, BS ;
PARKER, RM .
TOXICOLOGY, 1991, 69 (03) :291-300
[10]   Anticonvulsants and drugs for neurological disease [J].
Lowe, SA .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2001, 15 (06) :863-876